ATX inhibitor 25 (Compound 29) is an orally active Autotaxin inhibitor with an IC 50 of 1.08 nM. ATX inhibitor 25 exhibits excellent in vitro metabolic stability, with a t 1/2 of more than 170 minutes. In the bleomycin ( HY-108345 )-induced pulmonary fibrosis mouse model, orally administered ATX inhibitor 25 shows anti-fibrotic effects.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Phosphodiesterase (PDE)
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.